Breaking News
Get 45% Off 0
💰 With a 129% YTD gain in the bag, these are our AI’s top global picks for March
Read now

Stock Markets Analysis & Opinion

Contribute
Callum Thomas
10 Enduring Charts from 2024 to Navigate the Year Ahead By Callum Thomas - Dec 30, 2024

This week it’s a slightly different focus than usual given the quieter time-of-year — this edition takes a look at some of the most notable and enduring charts from the past year (similar to this...

Jordan Roy-Byrne, CMT
Gold Stocks Could Be Getting Ready for a Breakout in 2025 By Jordan Roy-Byrne, CMT - Dec 30, 2024

It has been a good year for precious metals but not a great one as the leveraged side has underperformed. Gold has gained 28% yet has outperformed Silver and the gold and silver stocks which are up...

Dr. Arnout ter Schure
Nasdaq 100: Should You Buy This Dip? By Dr. Arnout ter Schure - Dec 27, 2024 17

For those new to our Elliott Wave-based analyses and as a reminder to our regular readers, we have been tracking an ending diagonal (ED) pattern for the Nasdaq 100 for over a month. In our previous...

Thomas Hughes
Anavex Life Sciences: Short-Squeeze Target Gains Traction By Thomas Hughes - Dec 27, 2024

Anavex Life Sciences (NASDAQ: NASDAQ:AVXL) is a short-squeeze candidate because its share prices are rising on good news, institutional and analyst support is growing, and the short-sellers are...

Continue with Apple
Continue with Google
or
Sign up with Email